ATRC - Company ID 0001323885
The table below shows AtriCure, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$4.00M | -$11.03M | -$21.02M | -$4.08M | -$24.63M | -$9.32M |
| Capital expenditure | $3.85M | $2.18M | $2.77M | $2.50M | $3.38M | $1.33M |
| Investing cash flow | -$3.85M | -$1.68M | $9.64M | $28.81M | $19.72M | $63.59M |
| Dividends paid | - | - | - | - |
AtriCure, Inc. reported operating cash flow of $57.33M for fiscal year 2025. That is up 369.8% from $12.20M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$15.12M (FY 2016) to $57.33M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$13.26M | -$10.32M | -$7.86M | -$5.52M | -$10.50M | -$10.71M |